From Schedule 1 to Schedule 3: What does marijuana rescheduling mean for your organization?
An executive order reclassifying medical marijuana was issued at the end of 2025, marking a historic shift with far-reaching implications for healthcare. Join us as we explore the impact this may have on organizational marijuana policies, employee use, patient care, drug testing, accommodations, HIPAA considerations, and key HR and business decisions so your agency can respond proactively and compliantly.
KEY WEBINAR TAKEAWAYS
How historic marijuana rescheduling does — and does not — impact hospice and home care company employees, patients, and business processes
Current legal status of medical marijuana in light of historic rescheduling
How reclassification affects your marijuana policy and procedures
BONUS MATERIALS
Whitepaper: Marijuana Policy & Best Practices: Handling Employee Medical & Recreational Use
Marijuana Rules: Guidelines for Creating Effective Cannabis Policy & Procedures
WEBINAR DETAILS
At year-end 2025, the long-awaited rescheduling of marijuana took a big step forward when President Trump signed an executive order reclassifying medical marijuana from a Schedule 1 drug (on par with heroin) to a Schedule 3 drug (comparable to Tylenol® with Codeine No. 3). Once enshrined as law, the historic rescheduling of medical marijuana will favorably impact the cannabis industry — and potentially could impact hospices and home care companies. This webinar will discuss what marijuana reclassification does (and does not) mean for the healthcare industry. Learn what this rescheduling means (or does not mean) for your organization’s marijuana policy, people, patients, testing program, terminations, accommodations, and other HR, HIPAA, and business issues.
THIS WEBINAR WILL BENEFIT THE FOLLOWING AGENCIES:
Hospice
Home Care
Home Health
Palliative Care
WHO SHOULD ATTEND?
Compliance
HR
Training
Legal
Managers and executives
Anyone responsible for workplace policy and compliance
TAKE-AWAY TOOLKIT
Employee training log
Interactive quiz
PDF of slides and speaker’s contact info for follow-up questions
Attendance certificate provided to self-report CE credits
NOTE: All materials are subject to copyright. Transmission, retransmission, or republishing of any webinar to other institutions or those not employed by your institution is prohibited. Print materials may be copied for eligible participants only.
